MyBlueDotsPureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) MyBlueDots2 months ago01 mins BOSTON–(BUSINESS WIRE)–PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) Post navigation Previous: Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresNext: What Illinois residents should know, following the first US death from bird virus
Low doses of antibiotic work just as well as higher ones to treat rare type of chronic hair loss, study finds MyBlueDots33 minutes ago 0
Some nicotine pouch flavors are much more addictive than others, research suggests MyBlueDots33 minutes ago 0
Fewer than half of Medicaid managed care plans provide all FDA-approved medications for alcohol use disorder MyBlueDots7 hours ago 0